LSBCF (LakeShore Biopharma Co) Goodwill-to-Asset: 0.00 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is LakeShore Biopharma Co Goodwill-to-Asset?

LakeShore Biopharma Co LSBCF Goodwill-to-Asset is 0.00 as of Mar. 2025.

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. LakeShore Biopharma Co's Goodwill for the quarter that ended in Mar. 2025 was $0.00 Mil. LakeShore Biopharma Co's Total Assets for the quarter that ended in Mar. 2025 was $188.66 Mil. Therefore, LakeShore Biopharma Co's Goodwill to Asset Ratio for the quarter that ended in Mar. 2025 was 0.00.

LakeShore Biopharma Co  (OTCPK:LSBCF) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.

LakeShore Biopharma Co Goodwill-to-Asset Related Terms

LakeShore Biopharma Co Goodwill-to-Asset Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Goodwill-to-Asset Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Goodwill-to-Asset
0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

LSBCF vs ACUT, PPCB, ENSC: Goodwill-to-Asset Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Goodwill-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Goodwill-to-Asset falls into.


LakeShore Biopharma Co Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

LakeShore Biopharma Co's Goodwill to Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Goodwill to Asset (A: Mar. 2025 )=Goodwill/Total Assets
=0/188.661
=0.00

LakeShore Biopharma Co's Goodwill to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Goodwill to Asset (Q: Mar. 2025 )=Goodwill/Total Assets
=0/188.661
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Goodwill-to-Asset →
What does a Goodwill-to-Asset of 0.00 mean?
LakeShore Biopharma Co (LSBCF) has a Goodwill-to-Asset of 0.00 as of Mar. 2025. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Goodwill-to-Asset too high?
LakeShore Biopharma Co's current Goodwill-to-Asset is 0.00.
How does LakeShore Biopharma Co's Goodwill-to-Asset compare to ACUT and PPCB?
LakeShore Biopharma Co's Goodwill-to-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Goodwill-to-Asset for a Biotechnology company?
A good Goodwill-to-Asset depends on the Biotechnology industry context. However, Goodwill-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Goodwill-to-Asset mean?
A high Goodwill-to-Asset can signal that a stock is expensive relative to its fundamentals. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Goodwill-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Goodwill-to-Asset of 0.00. The current Goodwill-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Goodwill-to-Asset calculated?
Goodwill-to-Asset is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Goodwill-to-Asset is 0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.